A detailed history of Two Sigma Investments, LP transactions in Io Biotech, Inc. stock. As of the latest transaction made, Two Sigma Investments, LP holds 30,000 shares of IOBT stock, worth $27,000. This represents 0.0% of its overall portfolio holdings.

Number of Shares
30,000
Holding current value
$27,000
% of portfolio
0.0%

Shares

1 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 14, 2024

BUY
$0.75 - $1.64 $22,500 - $49,200
30,000 New
30,000 $31,000

Others Institutions Holding IOBT

About IO Biotech, Inc.


  • Ticker IOBT
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 28,815,300
  • Market Cap $25.9M
  • Description
  • IO Biotech, Inc., a clinical-stage biopharmaceutical company, develops immune-modulating cancer therapies based on the T-win technology platform. The company's lead product candidate, IO102-IO103, which is designed to target immunosuppressive proteins, such as Indoleamine 2,3-dehydrogenase (IDO), and programmed death-ligand (PD-L1) that is in ph...
More about IOBT
Track This Portfolio

Track Two Sigma Investments, LP Portfolio

Follow Two Sigma Investments, LP and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Two Sigma Investments, LP, based on Form 13F filings with the SEC.

News

Stay updated on Two Sigma Investments, LP with notifications on news.